Serena Williams Disclosed Her GLP-1 Use, But Experts Say Weight Loss Is Not Performance
Serena Williams disclosed her GLP-1 use in 2025, and a Ro banner over the Cincinnati Open turned that into a debate about competitive advantage. Experts interviewed by PopSugar say no clinical evidence shows the drugs enhance elite athletic performance, and WADA is monitoring rather than prohibiting them.
0views
0comments